Pancrelipase
Loading...Pancrelipase Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
Should hypersensitivity occur, discontinue medication and treat symptomatically.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
Pancrelipase capsules are indicated for patients with exocrine pancreatic enzyme deficiency as in but not limited to: cystic fibrosis, chronic pancreatitis, post-pancreatectomy, post-gastrointestinal bypass surgery (e.g. Billroth II gastroenterostomy), ductal obstruction from neoplasm (e.g. of the pancreas or common bile duct).
History
There is currently no drug history available for this drug.
Other Information
Pancrelipase 20,000 capsules are orally administered and contain delayed-release microspheres of porcine pancreatic enzyme concentrate, predominantly pancreatic lipase, amylase and protease.
Each 20,000 capsule contains:
Lipase 20,000 USP Units
Amylase 56,000 USP Units
Protease 44,000 USP Units
Inactive Ingredients:
Diethyl Phthalate NF, Hydroxypropyl Methylcellulose USP, Hypromellose Phthalate NF, Polyethylene Glycol NF, and Povidone USP.
Sources
Pancrelipase Manufacturers
-
Kaiser Foundation Hospitals
![Pancrelipase Capsule, Delayed Release [Kaiser Foundation Hospitals]](/wp-content/themes/bootstrap/assets/img/loading2.gif)
Pancrelipase | Kaiser Foundation Hospitals
Dosage should be adjusted according to the severity of the exocrine pancreatic enzyme deficiency. The number of capsules or capsule strength given with meals and/or snacks should be estimated by assessing which dose minimizes steatorhea and maintains good nutritional status. Dose increases if required, should be made slowly, with careful monitoring of response and symptomatology. It is important to ensure adequate hydration of patients at all times while dosing Pancrelipase capsules. In some patients with pancreatic enzyme deficiency, satisfactory responses have been achieved with dosages (expressed in U.S.P. units of lipase) similar to the ones stated below. However, dosages should be adjusted according to the response of the patient.
Children 7 to 12 years: 4,000 to 12,000 units (more if necessary) with each meal and with snacks.
Children 1 to 6 years: 4,000 to 8,000 units with each meal and 4,000 units with snacks.
Children under 1 year: Dosage for children under 6 months of age has not been established. Children 6 months to 1 year have responded to 2,000 units of lipase per meal.
The assessment of the end points in children is aided by charting growth curves.
Adults: 4,000 to 20,000 units (more if necessary) with each meal and with snacks.
-
X-gen Pharmaceuticals, Inc.
Pancrelipase | Djb Gas Services, Inc
There is currently no dosage information available for this product. We apologize for any inconvenience.
![Pancrelipase Capsule, Delayed Release [X-gen Pharmaceuticals, Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=dc8cfd84-258b-45bd-be80-90558338bbe0&name=oxygen.jpg)
Login To Your Free Account